Emerging Paradigm for the Management of mNSCLC

 

ecancer
Avatar

AACR 2024 Insights: "FLAURA2 Exploratory Analysis of Baseline and On-Treatment Plasma EGFRm Dynamics in Patients With EGFRm Advanced NSCLC Treated With 1L Osimertinib & Platinum-Pemetrexed"

By ecancer FEATURING Pasi Janne
By ecancer FEATURING Pasi Janne
124 views
April 26, 2024
0 Comments
Login to view comments. Click here to Login
Emerging Paradigm for the Management of mNSCLC
18:09
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

The Changing Prognosis of Lung Cancer Brain Metastases

Feat. S. Goldberg
05:04
ecancer

AACR 2024 Insights: "FLAURA2 Exploratory Analysis of Baseline a…

Feat. P. Janne
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

2024 Neuro-Oncology Update: NSCLC and Brain Mets

Feat. T. McGranahan
06:16
Rajat Thawani

The Importance of Liquid Biopsy in Advanced NSCLC

05:12
Rush University Medical Center

Current Unmet Needs and Challenges in 1L Treatment Approaches for EG…

Feat. M. Fidler
13:21
Yale Cancer Center

Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanc…

Feat. A. Nassar
07:43
Yale Cancer Center

2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertini…

Feat. P. Janne